NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Indian Equity Benchmark Indices Rebound on Monday

The equity benchmark indices Sensex and Nifty rebounded on Monday after three sessions of losses, supported by gains in Sun Pharmaceutical Industries shares and positive global market trends. At around 10 am, the Sensex rose 546.64 points to 77,210.85, while the broader Nifty climbed 169.55 points to 24,067.50.

Key Driver Behind the Rebound

Shares of Sun Pharmaceutical Industries surged over 7 percent after the company announced it will acquire US-based Organon & Co in an all-cash deal at an enterprise valuation of USD 11.75 billion. The firm's market valuation increased by Rs 27,462.59 crore to Rs 4,16,142.85 crore during morning trade.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Sectoral Indices Perform Well

Most sectoral indices on the NSE traded in the green, with the Nifty private bank index being the only laggard. The broader indices also showed strength, with the Nifty smallcap100 and Nifty midcap100 rising 1.6 percent and 1.2 percent, respectively.

Global Cues and Easing Geopolitical Concerns

The rebound in Indian equity indices can be attributed to firm global cues and easing geopolitical concerns. Recent reports indicated that Iran, through Pakistani mediators, offered a proposal to the United States on reopening the Strait of Hormuz and ending the conflict. US President Donald Trump also said on Sunday that Iran could initiate talks to negotiate an end to the two-month war, as reported by Reuters.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Global Market Performance

Japan's Nikkei 225 advanced 1.4 percent to 60,564.18, while South Korea's Kospi rose 2.1 percent to 6,617.94. China's Shanghai Composite index gained 0.2 percent to 4,089.04, and Taiwan's Taiex climbed 2.6 percent, led by buying in technology stocks. In the US, the S&P 500 rose 0.8 percent on Friday to close at 7,165.08, surpassing its previous record high. The Nasdaq Composite gained 1.6 percent to end at 24,836.60, supported by strength in technology shares.

Decline in India Vix

The India VIX, which measures market volatility and is often referred to as the fear gauge, declined nearly 5 percent to around the 19 level. A fall in the index indicates reduced uncertainty and improved investor confidence.

Market IndexFriday's CloseMonday's ClosePercentage Change
S&P 5007,165.08(not provided)0.8%
Nasdaq Composite24,836.60(not provided)1.6%
India VIX(not provided)19-5%

Market Outlook

Anand James, Chief Market Strategist at Geojit Investments, noted that Friday's gap-down opening weakened the bullish structure, opening room for a decline towards 23,500. However, with multiple resistances ahead, a break above at least 24,140 is required to assess prospects of 25,000–25,600. Otherwise, bears could regroup.

Investor Takeaway

Investors should be cautious of the market's volatility and keep an eye on the impact of the Iran peace proposal on global markets.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.